[1] Minotti G, Menna P, Salvatorelli E, et al.Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity[J].Pharmacol Rev, 2004, 56(2):185-229. [2] 张晓景. 硫普罗宁的药理作用及临床应用[J].中国药业, 2005, 15(8):91-92. [3] 阳冠明, 李树全, 叶司原, 等.氨基胍对阿霉素所致大鼠心肌毒性损伤的影响[J].中国药理学通报,2002, 18(5):552-555. [4] Ravkide J, Horder M, Gehardt W, et al.Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction[J].Scand J Clin Lab Invest, 1993, 53(7):677-685. [5] 李咏梅, 宋伯根, 赵桂芬, 等.盐酸阿霉素对大鼠心肌损伤的分子机制研究[J].中国临床药理学与治疗学, 2002, 7(3):209-212. [6] Singal PK, Iliskoie N, Li T, et al.Heart failure due to doxorubicin[J].Kuwait Med J, 2001, 33(2):111-115. [7] Muraoka S, Miura T.Free radicals mediate cardiac toxicity induced by adriamycin[J].Yakugaru Zasshi, 2003, 123(10):855-866. [8] Fogli S, Nieri P, Breschi MC, The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage[J].FASEB J, 2004, 18(6): 664-675. [9] Pacher P, Liauded L, Bai P, et al.Potent metalloporphyrin peroxynitrite decomposition catalyst protect against the development of doxorubicin-induced cardiac dysfunction[J].Circulation, 2003, 107(6):896-904. [10] Weinstein DM, Mikm MJ, Bauer JA.Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice[J].J Pharmacol Exp Ther, 2000, 294(1):396-401. [11] Ishiyama S, Hiroem, Nishikawa T, et al.Nitric oxide contributes to progression of myocardial in rats[J].Circulation, 1997, 95(2):489-496 |